Literature DB >> 1671844

Changes in hepatic glutathione metabolism in diabetes.

S V McLennan1, S Heffernan, L Wright, C Rae, E Fisher, D K Yue, J R Turtle.   

Abstract

Glutathione is important in the regulation of the redox state, and a decline in its tissue level has often been considered to be indicative of increased oxidative stress in diabetes. In this study of diabetic rats, the level of hepatic glutathione was normal unless food intake was restricted. Thus, the previous report of a reduction in hepatic glutathione in diabetes is likely to be the result of food deprivation rather than diabetes alone. In contrast to changes characteristic of oxidative stress, the efflux of glutathione in bile from diabetic animals was significantly decreased, whereas hepatic mixed disulfides were unchanged, and the hepatic gamma-glutamyltransferase activity was considerably increased. These changes were not reproduced by food deprivation. The decrease in biliary excretion of glutathione in diabetes may reflect an attempt to conserve glutathione by activation of the hepatic gamma-glutamyl cycle. We conclude that the disturbances of glutathione metabolism in diabetes are not typical of those seen in oxidative stress or food restriction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671844     DOI: 10.2337/diab.40.3.344

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats.

Authors:  Ozkan Ates; Neslihan Yucel; Suleyman R Cayli; Eyup Altinoz; Saim Yologlu; Ayhan Kocak; Celal Ozbek Cakir; Yusuf Turkoz
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

2.  Diabetes-induced alteration of HMGCoA reductase forms in rat livers.

Authors:  F Magni; M Cancellieri; M Del Puppo; M Galli Kienle
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

3.  Alterations in tissue glutathione antioxidant system in streptozotocin-induced diabetic rats.

Authors:  D H Mak; S P Ip; P C Li; M K Poon; K M Ko
Journal:  Mol Cell Biochem       Date:  1996-09-20       Impact factor: 3.396

4.  Evaluation of antioxidants in the kidney of streptozotocin induced diabetic rats.

Authors:  D Gomathi; M Kalaiselvi; G Ravikumar; K Devaki; C Uma
Journal:  Indian J Clin Biochem       Date:  2013-05-28

5.  Neonatal hyperglycemia induces oxidative stress in the rat brain: the role of pentose phosphate pathway enzymes and NADPH oxidase.

Authors:  Andrea Pereira Rosa; Carlos Eduardo Dias Jacques; Laila Oliveira de Souza; Fernanda Bitencourt; Priscila Nicolao Mazzola; Juliana Gonzales Coelho; Caroline Paula Mescka; Carlos Severo Dutra-Filho
Journal:  Mol Cell Biochem       Date:  2015-02-15       Impact factor: 3.396

6.  Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes.

Authors:  Hayder A Al-Aubaidy; Herbert F Jelinek
Journal:  Redox Rep       Date:  2014-01-13       Impact factor: 4.412

7.  Insulin and glucocorticoid dependence of hepatic gamma-glutamylcysteine synthetase and glutathione synthesis in the rat. Studies in cultured hepatocytes and in vivo.

Authors:  S C Lu; J L Ge; J Kuhlenkamp; N Kaplowitz
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Free Radical Scavenging Activity of Calotropis gigantea on Streptozotocin-Induced Diabetic Rats.

Authors:  N R Rathod; I Raghuveer; H R Chitme; R Chandra
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

9.  Polypharmacy (herbal and synthetic drug combination): a novel approach in the treatment of type-2 diabetes and its complications in rats.

Authors:  Rupinder Kaur; Muhammad Afzal; Imran Kazmi; Iqbal Ahamd; Zubair Ahmed; Babar Ali; Sayeed Ahmad; Firoz Anwar
Journal:  J Nat Med       Date:  2012-11-15       Impact factor: 2.343

10.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.